[212Pb]Pb-ADVC001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [212Pb]Pb-ADVC001, covering 2026-02-20 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study). [Phase 1, Phase 2]